Adam Keeney is Head of Corporate Development of BIOGEN INC.. Currently has a direct ownership of 1,900 shares of BIIB, which is worth approximately $270,826. The most recent transaction as insider was on Feb 07, 2025, when has been sold 563 shares (Common Stock) at a price of $141.35 per share, resulting in proceeds of $79,580. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.9K
187.01% 3M change
n/a 12M change
Total Value Held $270,826

Adam Keeney Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 07 2025
SELL
Payment of exercise price or tax liability
$79,580 $141.35 p/Share
563 Reduced 22.86%
1,900 Common Stock
Feb 07 2025
BUY
Exercise of conversion of derivative security
-
1,801 Added 42.24%
2,463 Common Stock
May 01 2024
SELL
Payment of exercise price or tax liability
$59,651 $216.13 p/Share
276 Reduced 29.42%
662 Common Stock
May 01 2024
BUY
Exercise of conversion of derivative security
-
938 Added 50.0%
938 Common Stock
AK

Adam Keeney

Head of Corporate Development
Cambridge, MA

Track Institutional and Insider Activities on BIIB

Follow BIOGEN INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIIB shares.

Notify only if

Insider Trading

Get notified when an Biogen Inc. insider buys or sells BIIB shares.

Notify only if

News

Receive news related to BIOGEN INC.

Track Activities on BIIB